Antineoplastic protocols: between effectiveness and adverse effects
Lucchi, E.; Molitor, J.L.
Presse Medicale 27(11): 527-529
1998
ISSN/ISBN: 0755-4982 PMID: 9841354 Document Number: 492547
Document emailed within 1 workday
Related Documents
Quatresooz, P.; Rorive, A.; Paquet, P.; Piérard-Franchimont, C.; Piérard, G.E. 2009: Cutaneous adverse effects predicting the efficacy of targeted antineoplastic therapies Revue Medicale de Liege 64(5-6): 347-350Cherenkov, V.G.; Petrov, A.B.; Shpenkova, A.A.; Vasil'eva, T.M. 2012: Use of Reamberin for the prevention of adverse effects of combined antineoplastic agents in stage III-IV ovarian cancer during induction treatment Voprosy Onkologii 58(1): 110-114
Kośmicki, M.; Sadowski, Z. 1992: Evaluation of clinical effectiveness and adverse effects of Polnitrin Wiadomosci Lekarskie 45(5-6): 165-169
Hernádi, Z.; Juhász, B.; Póka, R.; Mahunka, I.; Lampé, L. 1987: Analysis of the effectiveness and adverse effects of the drug combinations CAP and CEP in the therapy of patients in the advanced stages of ovarian cancer Orvosi Hetilap 128(47): 2457-2461
Janiec, W.; Pietryka, B.; Sliwiński, L.; Leszczyńska, J. 1985: Adverse effects of nonsteroid anti-inflammatory drugs. I. Adverse effects of salicylic, phenylacetic and propionic acids Wiadomosci Lekarskie 38(22): 1613-1619
Stricker, B.H.; Ottervanger, J.P.; van der Klauw, M.M. 1994: Registration of suspected adverse effects by the Bureau Adverse Effects Drugs; research activities in 1993 Nederlands Tijdschrift Voor Geneeskunde 138(42): 2110-2113
Gerdén, B. 2005: The Medical Products Agency about SSRi to pregnant women and adverse effects on the fetus. Long-term adverse effects are not proved, documentation is insufficient, more research is necessary Lakartidningen 102(10): 791
Janiec, W.; Pietryka, B.; Pytlik, M.; Leszczyńska, J. 1985: Adverse effects of non-steroidal anti-inflammatory drugs. II. Adverse effects of heterocyclic enols Wiadomosci Lekarskie 38(24): 1745-1750
Ciprandi, G.; Scordamaglia, A.; Bagnasco, M.; Canonica, G.W. 1987: Pharmacologic treatment of adverse reactions to foods: comparison of different protocols Annals of Allergy 58(5): 341-343
Sepúlveda, B. 1970: Adverse effects of contraceptives. II. Adverse effects of contraceptive steroids on the liver Gaceta Medica de Mexico 100(8): 823-831
Gram, L.F. 1977: Adverse effects during treatment with beta receptor blockaders. Report from the Adverse Drug Reaction Committee 1968-1976 Ugeskrift for Laeger 139(35): 2065-2068
Bogush, T.A.; Bogush, E.A.; Durnov, L.A.; Syrkin, A.B. 2002: The drop in toxicity and the rise in the effectiveness of antineoplastic chemotherapy by correcting the activity of liver monooxygenases: from the experiment to the clinical practice Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1: 37-42
Jaźwińska-Tarnawska, E.; Wiela-Hojeńska, A.; Wolańczyk-Medrala, A.; Patkowski, J.; Nittner-Marszalska, M.; Głowacka, K. 2012: Monitoring of NSAIDs adverse effects based on spontaneous reports from Wrocław regional adverse drug reactions monitoring center Acta Poloniae Pharmaceutica 69(5): 979-984
Saito, A.; Yamaji, T.; Saigusa, M. 1986: Adverse effects of antimicrobiological agents and countermeasures--TDM and countermeasures against adverse effects Nihon Rinsho. Japanese Journal of Clinical Medicine 44(4): 955-958
De Bont, J.M.; van der Holt, B.; Dekker, A.W.; van der Does-van den Berg, A.; Sonneveld, P.; Pieters, R. 2005: Adolescents with acute lymphatic leukaemia achieve significantly better results when treated following Dutch paediatric oncology protocols than with adult protocols Nederlands Tijdschrift Voor Geneeskunde 149(8): 400-406
Ember, I.; Raposa, T.; Varga, C.; Herceg, L.; Kiss, I. 1995: Carcinogenic effects of cytostatic protocols in CBA/Ca mice In Vivo 9(1): 65-69
Cohen, S.C.; Gabelnick, H.L.; Johnson, R.K.; Goldin, A. 1975: Effects of antineoplastic agents on wound healing in mice Surgery 78(2): 238-244
Hambsch, K.; Fischer, H. 1984: Drug side effects in antineoplastic and immunosuppressive cytostatic therapy Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 39(1): 7-14
Sironi, M.; Canegrati, M.A.; Romano, M.; Vecchi, A.; Spreafico, F. 1984: Chemotherapy-increased antineoplastic effects of antibody-toxin conjugates Cancer Treatment Reports 68(4): 643-645
Ringborg, U. 1983: The importance of controlling the side effects of antineoplastic therapy with cisplatin Lakartidningen 80(21): 2240-2241